CS logo
small CS logo
Hematology-Oncology Medical Group of Fresno, Inc.

Fresno, California, United States

About Hematology-Oncology Medical Group of Fresno, Inc.


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Hematology-Oncology Medical Group of Fresno, Inc.


During the past decade, Hematology-Oncology Medical Group of Fresno, Inc. conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Hematology-Oncology Medical Group of Fresno, Inc." #1 collaborator was "Celgene Corporation" with 1 trials as a collaborator and "UCB Pharma" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

Clinical Trials Conditions at Hematology-Oncology Medical Group of Fresno, Inc.


According to Clinical.Site data, the most researched conditions in "Hematology-Oncology Medical Group of Fresno, Inc." are "Lymphoma, Non-Hodgkin" (1 trials) and "Multiple Myeloma" (1 trials). Many other conditions were trialed in "Hematology-Oncology Medical Group of Fresno, Inc." in a lesser frequency.

Clinical Trials Intervention Types at Hematology-Oncology Medical Group of Fresno, Inc.


Most popular intervention types in "Hematology-Oncology Medical Group of Fresno, Inc." are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "DVD-R" (1 trials), "Inotuzumab ozogamicin" (1 trials), "Rituximab" (1 trials), "rituximab + gemcitabine" (1 trials) and "rituximab +bendamustine" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Hematology-Oncology Medical Group of Fresno, Inc.


The vast majority of trials in "Hematology-Oncology Medical Group of Fresno, Inc." are 2 trials for "All" genders.

Clinical Trials Status at Hematology-Oncology Medical Group of Fresno, Inc.


Currently, there are NaN active trials in "Hematology-Oncology Medical Group of Fresno, Inc.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Hematology-Oncology Medical Group of Fresno, Inc., undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Hematology-Oncology Medical Group of Fresno, Inc., 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".